The IPO Buzz: Generate Biomedicines Prices IPO at $16 Mid-Point & Stock Falls in NASDAQ Debut

AI-driven Generate Biomedicines  (GENB) priced its IPO at $16.00 – the mid-point of its range – and sold 25 million shares – the number in the prospectus – to raise $400 million on Thursday night, Feb. 26, 2026. Generate Biomedicines (GENB) shares slid $1.00 to start trading at $15.00 on NASDAQ shortly before 1 p.m. EST on Friday, Feb. 27, 2026. The biotech's NASDAQ debut ca..

Read more February 27, 2026

IPO Calendar

Company Symbol proposed Lead Managers Shares (Millions) Price Low Price High Est. $ Volume Expected to Trade SCOOP Rating Rating Change
FreeCast (Direct Listing) FCST Maxim Group (Financial Advisor) 19.8 0.00 0.00 $ 0.0 mil 3/3/2026 Tuesday S/O S/O
MiniMed Group, Inc. MMED Goldman Sachs/BofA Securities/Citigroup/Morgan Stanley/Barclays/Deutsche Bank Securities/Mizuho/Wells Fargo Securities/ 28.0 25.00 28.00 $ 742.0 mil 3/5/2026 Thursday S/O S/O
BW Industrial Holdings BWGC Eddid Securities USA 2.6 7.00 9.00 $ 21.0 mil 3/9/2026 Week of S/O S/O
Read more

Last 100 IPOs - February 28, 2026

Number of IPOs priced : 100
Number Up: 55
Number Down: 39
Number Unchanged: 6
Percentage Change From Issue Price: -3.39%
Percentage Change for The Nasdaq Composite 35.22%

2026 IPO Scorecard - February 28, 2026

Number of IPOs priced (Excluding 48 units) : 31
Number Up: 17
Number Down: 10
Number Unchanged: 4
Total Return From Issue Price: 4.00%
The Nasdaq Composite Index YTD % Change 35.22%